-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - [-1.01 to
5.01]
Mean difference at
endpoint
-20.00 [-85.19 to
45.19]
Hindley 20046
RCT
6 weeks … (2.4)* 2/41 (4.9) NR
RR [95% CI] 0.91 [0.19 to 4.26] 0.91 [0.13 to 6.18]
Hindley, 20046
RCT
6 weeks … † Botulinum - transitory exacerbation of per-existing urine incontinence for 2 weeks, lidocaine -anal … sildenafil citrate and placebo patients.12 Tang et al. report
substantial reductions in PVRs after 2 weeks … sildenafil
citrate (n=20)
NR 1/20 (0.05) NR NR NR
Tang, 200613
RCT
2 weeks
placebo
(n=20
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
December 01, 2011 - Peer Reviewer #5 Methods Pg. 33 line 5 “RCTs of at least 6 weeks duration and an adult
study population … Peer Reviewer #5 Results KQ1 Page 91 or page 77, line 29-31
After 12 weeks of treatment, significantly
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
September 01, 2020 - One session +
supplementary session
for chief investigator;
3-4 visits for GP
Once a week for 4 weeks … reported as received
by a parent in the past
12 months, daily use
of inhaled steroids in
the past 4 weeks … , and
daily use of controller
medications in the past
4 weeks. … 12 months, and
parent report of how
limited their child had
been from asthma in
the previous 2 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - of instillation regimen, classified as single
instillation, induction therapy (treatment for 4 to 8 weeks … ),
maintenance therapy (treatment for longer than 8 weeks),
or other. … 13
• One trial of patients with higher risk NMIBC found
that MMC 20 mg induction therapy for 6 weeks … Limited evidence suggested that BCG maintenance
regimens (>6 weeks) are more effective than induction … regimens (≤6 weeks) at reducing risk of bladder cancer
recurrence in patients with higher risk tumors
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - ITCA
650 produced mean reductions in HbA1c of 1.4% at 39 weeks of treatment. … Over 39 weeks,
patients who received 60 mcg/day lost a mean of 4 kg, compared with 2 kg in the placebo … ITCA 650 produced sustained
mean reductions in HbA1c of 1.4% at 39 weeks of treatment (in a modified … The company announced that at 52 weeks, “ITCA 650 results
were superior vs. … After 24 weeks, Afrezza plus basal insulin therapy “provided a mean reduction in
HbA1c that met the
-
effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
January 28, 2016 - While 2 weeks of gluten challenge
can induce intestinal changes in many adults, a
substantial proportion … We have revised to
include the ACG algorithm (Rubio-Tapa, 2013) that
recommends an additional six weeks … revised this
section to include the ACG algorithm (Rubio-Tapa,
2013) that recommends at least two weeks … challenge before conducting biopsy, and an
additional six weeks for adults who can tolerate.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
January 01, 2020 - unchanged since the schedule was first
published by the Children’s Bureau in 1930: monthly visits until 28 weeks … , every 2 weeks until
36 weeks, and weekly until delivery.10 The American College of Obstetricians and … for dating and viability and to
evaluate anatomy, respectively), a diabetes screen between 24 and 28 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
October 07, 2011 - Methods I am concerned about interpreting ‘long term’ as ’12 weeks or longer.’ … range of studies reporting on our
multiple outcomes, we opted to include
studies with a minimum of 12 weeks … the
publication reports TC mg/dL [-1 (0.4)] for candesartan and [- 12(5.6)]
for perindopril at 12 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
June 01, 2017 - design
Funding source Inclusion criteria Age range (y) Number of assessments/
followup duration (weeks … design
Funding source Inclusion criteria Age range (y) Number of assessments/
followup duration (weeks … design
Funding source Inclusion criteria Age range (y) Number of assessments/
followup duration (weeks … design
Funding source Inclusion criteria Age range (y) Number of assessments/
followup duration (weeks … waiting for a period of nine months with analysis by intention to treat
Maw 1999 10459904 TT within 6 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
June 01, 2012 - − The SRDR operational team will send out meeting minutes no later than
two weeks
after the meeting
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - The authors
reported the following results:58
After 26 treatment weeks, mean glycosylated hemoglobin … Confirmed hypoglycemia rates (plasma glucose
<3.1 mmol/L or severe hypoglycemia) were similar at weeks … the following results in May 2013:81
HbA1c was significantly lower in all groups after 12 and 24 weeks … Weight was reduced by 2.8-3.7 kg (P < 0.05) at 24 weeks in all except
the 20→20 μg/day group. … Benefit
occurred for both doses compared with sham at 3 weeks and all subsequent time
points.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - The
recommended initial adult dose is
either 2.25 mcg/kg SC weekly or
500 mcg SC every 3 weeks. … group given Epoetin (alpha or beta) or Darbepoetin subcutaneously
or intravenously for at least four weeks … Was epoetin (alfa or beta) or darbepoetin given subcutaneously or
intravenously for at least four weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - orally, twice daily, had
significant improvements in lung function and fewer exacerbations after 24 weeks … of patients with declining lung function or who died compared with patients
given placebo after 52 weeks … smaller decline in lung
function compared with lung function in patients given placebo, after 52 weeks … patients begin with one capsule
(267 mg) three times daily, and titrate to the full dosage after 2 weeks … with IPF were treated with pirfenidone three times daily (for a total of 801 mg) or placebo
for 52 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
January 01, 2007 - The NNT to gain one additional responder
at 6 to 12 weeks with sertraline was 14 (95-percent
CI, 8-22 … The NNT to gain one
additional responder at 6 to 12 weeks with
venlafaxine was 12 (95-percent CI, 7-50 … The NNT to yield one additional responder after 1 or 2
weeks of treatment is 7 (95-percent CI, 5-12); … after 4
weeks of treatment, however, most response rates were
similar. … Mean weight gains
compared to pretreatment ranged from 0.8 kg to
3.0 kg after 6 to 8 weeks of treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
March 01, 2022 - Study Selection Criteria
Population
Adults with chronic pain (>12 weeks)
Interventions
Cannabinoids ( … nonpharmacologic therapy
Outcome: Pain, function, satisfaction, quality of life, and adverse events (≤ 4 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
January 01, 2018 - Tolle, 2008 Fair NPP (DPN) PGB/GBP Pregabalin 150 mg/d 12
Rebecca Jungbauer: Rebecca Jungbauer:
8 weeks … Tolle, 2008 Fair NPP (DPN) PGB/GBP Pregabalin 300 mg/d 12
Rebecca Jungbauer: Rebecca Jungbauer:
8 weeks … Tolle, 2008 Fair NPP (DPN) PGB/GBP Pregabalin 600 mg/d 12
Rebecca Jungbauer: Rebecca Jungbauer:
8 weeks … NR 7 101 NR
Tolle, 2008 Fair NPP (DPN) Placebo Placebo 12
Rebecca Jungbauer: Rebecca Jungbauer:
8 weeks … , for those who recorded fewer than 7 diary entries
Rebecca Jungbauer: Rebecca Jungbauer:
8 weeks, for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
January 01, 2020 - Are 2 weeks of daily breastfeeding support
insufficient to overcome the influences of
formula? … Methods
RCT
Intervention was 2 weeks of daily phone calls
by bilingual nurse immediately after discharge … p 24, l 30: I am familiar with another study that
examined # of BFHI steps and breastfeeding at
6 weeks … have met your review criteria
because the outcome is described as
discontinued breastfeeding at 6 weeks … rather
than breastfeeding at 6 weeks but I want to
mention.
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - fracture, health-related quality of life, glucose intolerance, malignancy, and mortality
T — At least 4 weeks … Again, to broaden the inclusion criteria as much as possible, we were open to studies at least 4 weeks … Step 11: After 2 weeks, the topic refinement document is discussed with key informants and questions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - 1149: the logic of the sentence is not clear: what is the
relationship between underpowered with 24 weeks … Published Online: March 10, 2010
Section Comment Response
from eligible NRS that were 24 weeks … atorvastatin 10-40 + ezetimibe vs. atorvastatin 20-80 as monotherapy
for the longest follow up of 14 weeks … E-10
Participants reaching ATPIII LDL-c goals (follow-up 18 weeks),
Participants with events – combination … "For the
efficacy analysis, the primary analysis will be an intention-to-treat
approach after 12 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
August 01, 2021 - Methods Research Report: Creating Efficiencies in the Extraction of Data From Randomized Trials
Methods Research Report
Creating Efficiencies in the Extraction of Data From
Randomized Trials: A Prospective Evaluation of a
Machine Learning and Text Mining Tool
Methods Research Report
Creating Efficie…